Skip to content

Waters Corporation WAT Waters Biosciences — Operating Income Loss Margin

Similar metrics at other companies

Fortune Brands Innovations logo
FBINWater — Operating Income
$103.7M+0.5%
Mueller Water Products logo
MWAWater Management Solutions — Operating Income (Loss)
$35.3M+12.8%
AWR
AWRWater: — Operating Income (Loss)
$38.7M+11.2%
Franklin Electric logo
FELEWater Systems — Operating Income (Loss)
$44.4M+2.3%
Ecolab logo
ECLWater Services — Operating Income
$297.8M+6.9%
Veralto logo
VLTOWater Quality — Operating Income (Loss)
$210M+6.1%

Other financials

Income statement

See full
Revenue$1.3B+91.4%
Gross profit$569.5M+8.6%
Operating income-$47.0M-131%
Net income-$72.0M-160%
EPS (diluted)-$0.87-143%

Balance sheet

See full
Cash & equivalents$462.0M+20.7%
Total debt$5.2B+263%
Total equity$15.3B+679%
Total assets$24.5B+434%

Cash flow

See full
Operating cash flow-$3.0M-101%
CapEx$39.0M+50.0%
Free cash flow-$42.0M-118%

Valuation

See full
Market cap$36.76B+78.1%
Enterprise value$41.51B+92.6%
P/E81.8×+50.6×
P/S9.8×+3.0×

Profitability

See full
Gross margin59.3%-0.1pp
Operating margin16%-12.3pp
Net margin11.9%-10.1pp
FCF margin7%-13.8pp

Returns & leverage

See full
Return on equity5.2%-35.6pp
Debt / equity0.3×-0.4×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Waters Corporation in its filing.

Tagged under the XBRL concept wat:OperatingIncomeLossMargin.

The official record: Waters Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Waters Corporation's waters biosciences — operating income loss margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Waters Corporation's waters biosciences — operating income loss margin?
Waters Corporation (WAT) reported waters biosciences — operating income loss margin of 35.8% in Q1 2026.
What does waters biosciences — operating income loss margin mean?
This metric represents the operating profitability of the Waters Biosciences business segment, calculated as operating income divided by net sales for this specific unit. It measures the efficiency with which the segment converts its revenue into profit after accounting for direct costs and allocated operating expenses. This figure is critical for assessing the underlying performance and margin contribution of the company's core analytical instrument and service offerings.